In vivo imaging of retinal gliosis: A platform for diagnosis of PD and screening of anti-PD compounds

2010 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC'10

Volumn , Issue , 2010, Pages 3049-3052

  Kumar, S ^a   Ho, G ^a   Zhang, Y ^a   Zhuo, L ^a  

^a Nanotechnology   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; CLINICAL SYMPTOMS; DOPAMINERGIC NEURONS; EARLY DETECTION; GLIAL FIBRILLARY ACIDIC PROTEINS; IN-VIVO; IN-VIVO IMAGING; MOLECULAR IMAGING; PARKINSON'S DISEASE; REACTIVE OXYGEN SPECIES; SUBSTANTIA NIGRA; SYNTHETIC ANTIOXIDANTS; THERAPEUTIC COMPOUNDS; TRANSGENIC MICE; UP-REGULATION;

BROMINE COMPOUNDS; DISEASES; ENZYME INHIBITION; NEURONS; OPHTHALMOLOGY; OXYGEN;

DIAGNOSIS;

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEIN; IMIDAZOLE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; CHEMISTRY; DISEASE COURSE; GENOTYPE; GLIOSIS; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MOUSE; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOLOGY; RETINA; TRANSGENIC MOUSE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; DISEASE PROGRESSION; DOPAMINE AGENTS; GENOTYPE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; GREEN FLUORESCENT PROTEINS; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; OXIDATIVE STRESS; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES; RETINA;

EID: 78650821429     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IEMBS.2010.5626122     Document Type: Conference Paper

References (18)

1. A. E. Lang and A. M. Lozano, "Parkinson's disease. First of two parts," N Engl J Med, vol. 339, pp. 1044-53, Oct 8 1998.
2. A. E. Lang and A. M. Lozano, "Parkinson's disease. Second of twoparts," N Engl J Med, vol. 339, pp. 1130-43, Oct 15 1998.
3. J. M. Fearnley and A. J. Lees, "Ageing and Parkinson's disease: substantia nigra regional selectivity," Brain, vol. 114 ( Pt 5), pp. 2283-301, Oct 1991.
4. V. Jackson-Lewis and S. Przedborski, "Protocol for the MPTP mouse model of Parkinson's disease," Nat Protoc, vol. 2, pp. 141-51, 2007.
5. P. L. McGeer and E. G. McGeer, "Inflammation and neurodegeneration in Parkinson's disease," Parkinsonism Relat Disord, vol. 10 Suppl 1, pp. S3-7, May 2004.
6. H. Yuan, J. C. Zheng, P. Liu, S. F. Zhang, J. Y. Xu, and L. M. Bai, "Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes," Neurosci Bull, vol. 23, pp. 125-30, Mar 2007.
7. M. Bornebroek, L. M. L. de Lau, M. D. M. Haag, P. J. Koudstaal, A. Hofman, B. H. C. Stricker, and M. M. B. Breteler, "Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease," Neuroepidemiology, vol. 28, pp. 193-196, 2007.
8. J. K. Mallajosyula, D. Kaur, S. J. Chinta, S. Rajagopalan, A. Rane, D. G. Nicholls, D. A. Di Monte, H. Macarthur, and J. K. Andersen, "MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology," PLoS One, vol. 3, p. e1616, 2008.
9. L. Zhuo, B. Sun, C. L. Zhang, A. Fine, S. Y. Chiu, and A. Messing, "Live astrocytes visualized by green fluorescent protein in transgenic mice," Dev Biol, vol. 187, pp. 36-42, Jul 1 1997.
10. L. Zhao, C. Zhang, L. Zhuo, Y. Zhang, and J. Y. Ying, "Imidazolium salts: a mild reducing and antioxidative reagent," J Am Chem Soc, vol. 130, pp. 12586-7, Sep 24 2008.
11. M. H. Abdel-Wahab, "Potential neuroprotective effect of tbutylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2'-methylphenyl) -1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in mice," J Biochem Mol Toxicol, vol. 19, pp. 32-41, 2005.
12. S. Kumar, G. Ho, K. M. Woo, and L. Zhuo, "Achieving cellular resolution for in vivo retinal images of transgenic GFAP-GFP mice via image processing," Opt Express, vol. 16, pp. 8250-62, May 26 2008.
13. S. Kumar, G. Ho, and L. Zhuo, "In Vivo Imaging and Quantification of Retinal Gliosis in Transgenic Mice " in PhotonicsGlobal@Singapore 2008. IPGC 2008. IEEE Singapore, 2008, pp. 1 - 4.
14. G. Ho, S. Kumar, X. S. Min, Y. L. Kng, M. Y. Loh, S. Gao, and L. Zhuo, "Molecular imaging of retinal gliosis in transgenic mice induced by kainic acid neurotoxicity," Invest Ophthalmol Vis Sci, vol. 50, pp. 2459-64, May 2009.
15. S. Kumar, G. Rajshekher, and S. Prabhakar, "Positron emission tomography in neurological diseases," Neurol India, vol. 53, pp. 149-55, Jun 2005.
16. A. J. Fischman, A. A. Bonab, J. W. Babich, E. P. Palmer, N. M. Alpert, D. R. Elmaleh, R. J. Callahan, S. A. Barrow, W. Graham, P. C. Meltzer, R. N. Hanson, and B. K. Madras, "Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters," Synapse, vol. 29, pp. 128-41, Jun 1998.
17. C. W. Olanow and W. G. Tatton, "Etiology and pathogenesis of Parkinson's disease," Annu Rev Neurosci, vol. 22, pp. 123-44, 1999.
18. N. K. Archibald, M. P. Clarke, U. P. Mosimann, and D. J. Burn, "The retina in Parkinson's disease," Brain, vol. 132, pp. 1128-45, May 2009.